N/A
N=25
TriActive+ Radiofrequency (RF) for Non-invasive Treatment of Wrinkles & Rhytides
Wrinkles · Rhytides
Bottom Line
View on ClinicalTrials.gov: NCT01460927 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcome: Primary: Fitzpatrick Classification of Wrinkling and Degree of Elastosis. — 5.6; 5.56; 5.36; 5.32 Fitzpatrick Classification Scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- TriActive+ RF (Device)
- Age
- Adult · 30+ yrs
- Sex
- All
- Sponsor
- Deka Medical, Inc.
- Primary completion
- Apr 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Fitzpatrick Classification of Wrinkling and Degree of Elastosis. |
5.6; 5.56; 5.36; 5.32; 4.88 | — |
Summary
The study objective is to evaluate the safety and efficacy of a radiofrequency (RF) source, the TriActive+ RF handpiece, for treatment of wrinkles and rhytides after multiple treatments. The primary endpoint is observation of changes to the surface by visual and photographic analysis. Secondary endpoints: measurement of patient satisfaction and comfort of the treatment and the measurement of adverse events.
Eligibility Criteria
Inclusion Criteria
- Informed consent agreement signed by the subject.
- Healthy male or female subjects 30-60 years of age.
- Having at least two facial sub-areas (left peri-orbital, right peri-orbital or peri-oral) with visible lines/wrinkles and elastosis, which correlate to a score of 2-6 on the Fitzpatrick Classification of Wrinkling and Degree of Elastosis.
- Willingness to follow the treatment and follow-up schedule and the post-treatment care.
- For female candidates - post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study (i.e., oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide, or abstinence).
Exclusion Criteria
- Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breastfeeding.
- Having any active electrical implant anywhere in the body, such as a pacemaker or an internal defibrillator.
- Having a permanent implant in the treated area, such as metal plates and screws, or an injected chemical substance.
- Having a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
- Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents) one week before and after each treatment session.
- Use of retinoids, antioxidants or skin nourishing supplements within 1 month of treatment or during the study.
- Having received a facial within 1 month of treatment or during the study.
- Having received a facial dermabrasion or chemical peel treatment within 2 months of treatment or during the study.
- Having received treatment with light, RF or other devices in the treated area within 6 months of treatment or during the study.
- Having received Botox in the treated area within 6 months of treatment or during the study.
- Having received collagen/Hyaluronic Acid (HA) in the treated area within a year of treatment or during the study.
- Having undergone a resurfacing procedure, face lift or eyelid surgery within a year of treatment or during the study.
- Having undergone any other surgery in the treated area within 6 months of treatment (or more if skin has not healed completely) or during the study.
- Having ever received fat injections or other methods of augmentation with injected or implanted material in the treated area or planning to during the study.
Data sourced from ClinicalTrials.gov (NCT01460927). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.